Healthcare, pharmacy and retail chain Walgreens on Monday announced the nationwide launch of Pixel by Labcorp COVID-19 at-home collection kit through Labcorp OnDemand, at no cost to individuals who meet clinical guidelines in collaboration with the US Department of Health and Human Services.
Through the launch, Walgreens said it will enable more communities to access reliable, convenient testing services. Individuals scheduling a testing appointment using the Walgreens online scheduler will see a pop-up with the option to request a COVID-19 at-home collection kit. Completed tests can be dropped off at more than 6,000 Walgreens locations or a FedEx drop off location.
The Labcorp COVID-19 at-home collection kits are shipped via FedEx Priority Overnight with step-by-step instructions to guide individuals through kit registration, sample collection and how to return your sample. Results are provided on average within one to two days after the specimen is received at the lab and can be accessed through the Labcorp OnDemand portal.
In April 2020, Labcorp launched at-home collection kits for COVID-19 PCR testing, which are now available through its Labcorp OnDemand platform, which includes wellness, allergy, COVID-19, women's health and fertility tests.
Individuals can purchase Labcorp OnDemand tests online, collect samples in the convenience of their home, or schedule test appointments at one of Labcorp's nearly 2,000 patient service centres, including Labcorp at Walgreens locations.
Inimmune signs research collaboration with Boston Children's Hospital
ResVita Bio receives USD250,000 phase one Small Business Innovation Research grant from NIAID
Phase II Data of Oral Dexpramipexole Published in Eosinophilic Asthma
AllerVie Health Rebrands Southern Allergy & Asthma
Applied BioCode Inks Distribution Agreement with Medline Industries
Vedanta Biosciences Receives Fast Track Designation for VE303
KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
French Ophthalmology Specialist Horus Pharma Group Launches a Nordic Subsidiary